Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Bullboard Posts
Post by narinderon Jun 28, 2000 9:28am
229 Views
Post# 2127972

Potential Valuation

Potential ValuationI have significant holdings in COT now (85,000 shares) much more then I would usually invest in a penny play but I have great confidence in this company. The last time I felt this confident in my investment is when I purchsed T.Ven @ $.30...since then I have made exceptional returns in large caps such as QLT, NT, JDU . COT like VEN is an exceptional play...the upside potential is great...they are in a market that as yet is not saturated and is in need of a market leader...they have an excellent product that is gaining wide acceptance and finally they have aggressive grow plans including a B2B arm of the company and potential aquisitions......MAKE NO MISTAKE ABOUT IT...with the right aquisitions this company can be transfprmed into a lmarket leader overnight....COT management has not lost site have this as well as various investment potential...COT is a potential goldmine for all involved and I believe we are going to see her explode shortly. Timberline has a market capitalization of $100,000,000 range assuming the COT's Q3 results indicate excellent growth and perhaps profitability for the quarter...it is resonable to assume a subsequent increase in COT's market capitalization....with a $100,000,000 market cap (which is small for todays tech plays) COT will have a share value in $3.30 range....you see with good Q# numbers and an aquistion on the horizon as $2.00 share price is very possible, On institutional buying...it is right when it is pointed out that large cap funds wouldn't invest in COT...but there is hundreds of smallcap/micro cap funds out here...they invest in companies that have the potentional to be the next mid/large cap plays...COT is one of them. The 100,000 blocks etc. can be retail buyers...but remember these buyers are not you typical day traders...these are experianced profesionals who are putting a significant amount of capital up due to there beleif that COT is about to significantly increase in Share value. Finally, I am encouraged by the recent news release because they have confirmed that the Q3's will be released anytime now and there are aquisitions on the horizon..also I would direct board members to the recent stockhouse interview which indicates these aquistions are 3-6 months away...there is definetly, without question someting cooking in the background!
Bullboard Posts